The choreography of cyclooxygenases in the kidney.
作者信息
FitzGerald G A
机构信息
Center for Experimental Therapeutics, School of Medicine, 153 Johnson Pavillion, 3620 Hamilton Walk, University of Pennsylvania, Philadelphia, PA 19104-6084, USA.
出版信息
J Clin Invest. 2002 Jul;110(1):33-4. doi: 10.1172/JCI16044.
Abstract
摘要
相似文献
1
The choreography of cyclooxygenases in the kidney.肾脏中环氧合酶的编排。
J Clin Invest. 2002 Jul;110(1):33-4. doi: 10.1172/JCI16044.
2
[New anti-inflammatory analgetics--are they needed?].[新型抗炎镇痛药——有必要研发吗？]
Duodecim. 1999;115(20):2217-24.
3
[The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].[环氧化酶-2（COX-2）抑制剂的心血管安全性]
Harefuah. 2002 Oct;141(10):922-4.
4
[Safe use of anti-inflammatory analgesics].[抗炎镇痛药的安全使用]
Duodecim. 2003;119(22):2167-71.
5
[NSAIDs for therapy of rheumatoid arthritis. Introduction].
Nihon Rinsho. 2005 Jan;63 Suppl 1:473-6.
6
The coxibs, selective inhibitors of cyclooxygenase-2.昔布类药物，即环氧化酶-2的选择性抑制剂。
N Engl J Med. 2001 Aug 9;345(6):433-42. doi: 10.1056/NEJM200108093450607.
7
[Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].[选择性环氧化酶-2抑制剂的研究现状及其应用评估]
Di Yi Jun Yi Da Xue Xue Bao. 2002 Feb;22(2):184-6.
8
Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?微粒体前列腺素E2合酶：比环氧化酶更安全的靶点？
Mol Interv. 2007 Aug;7(4):195-9, 180. doi: 10.1124/mi.7.4.5.
9
Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?非甾体抗炎药和COX-2选择性抑制剂是否具有不同的肾脏效应？
J Nephrol. 2002 Sep-Oct;15(5):480-8.
10
[The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].[非甾体抗炎药（NSAIDs）——COX-2抑制剂的使用]
Harefuah. 2002 Oct;141(10):920-1.
引用本文的文献
1
Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients.环氧化酶通路变异性对肾硬化患者心血管结局的影响。
Sci Rep. 2023 Jan 23;13(1):1253. doi: 10.1038/s41598-022-27343-z.
2
Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease.导致慢性肾病的细胞变化过程中的肾小球生物力学应激与脂质介质
Biomedicines. 2022 Feb 9;10(2):407. doi: 10.3390/biomedicines10020407.
3
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.非甾体抗炎药的心血管药理学
Trends Pharmacol Sci. 2017 Aug;38(8):733-748. doi: 10.1016/j.tips.2017.05.008. Epub 2017 Jun 23.
4
Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids.肾小球损伤与反应中与超滤相关的生物力学力：类花生酸的潜在作用。
Prostaglandins Other Lipid Mediat. 2017 Sep;132:59-68. doi: 10.1016/j.prostaglandins.2017.01.003. Epub 2017 Jan 17.
5
Use of NSAIDs in treating patients with arthritis.非甾体抗炎药在关节炎患者治疗中的应用。
Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S2. doi: 10.1186/ar4174. Epub 2013 Jul 24.
6
Prostaglandin E(2) is crucial in the response of podocytes to fluid flow shear stress.前列腺素 E（2）在足细胞对液流切应力的反应中起关键作用。
J Cell Commun Signal. 2010 Jun;4(2):79-90. doi: 10.1007/s12079-010-0088-9. Epub 2010 Apr 8.
7
Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.环氧化酶-2 依赖性前列环素形成与血压稳态：在小鼠中靶向交换环氧化酶同工型。
Circ Res. 2010 Feb 5;106(2):337-45. doi: 10.1161/CIRCRESAHA.109.204529. Epub 2009 Nov 25.
8
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.前列腺素F2α会升高血压并促进动脉粥样硬化。
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7985-90. doi: 10.1073/pnas.0811834106. Epub 2009 Apr 24.
9
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.心肌细胞环氧化酶-2影响心脏节律和功能。
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7548-52. doi: 10.1073/pnas.0805806106. Epub 2009 Apr 17.
10
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.环氧化酶、微粒体前列腺素E合酶-1与心血管功能
J Clin Invest. 2006 May;116(5):1391-9. doi: 10.1172/JCI27540. Epub 2006 Apr 13.
本文引用的文献
1
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.环氧化酶-1和-2活性对血管紧张素II升压反应的相反作用。
J Clin Invest. 2002 Jul;110(1):61-9. doi: 10.1172/JCI14752.
2
A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.罗非昔布与对照非选择性非甾体抗炎药治疗骨关节炎患者时不良肾血管事件的比较。
Curr Med Res Opin. 2002;18(2):82-91. doi: 10.1185/030079902125000354.
3
Role of prostacyclin in the cardiovascular response to thromboxane A2.前列环素在心血管系统对血栓素A2反应中的作用。
Science. 2002 Apr 19;296(5567):539-41. doi: 10.1126/science.1068711.
4
Relative risk of cardiovascular events in patients with rheumatoid arthritis.
Am J Cardiol. 2002 Mar 21;89(6A):33D-38D. doi: 10.1016/s0002-9149(02)02235-x.
5
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition.
Kidney Int. 2001 Dec;60(6):2324-9. doi: 10.1046/j.1523-1755.2001.00072.x.
6
The coxibs, selective inhibitors of cyclooxygenase-2.昔布类药物，即环氧化酶-2的选择性抑制剂。
N Engl J Med. 2001 Aug 9;345(6):433-42. doi: 10.1056/NEJM200108093450607.
7
Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2.血小板对内皮细胞环氧化酶-2及前列腺素合成的上调作用。血栓素A2的作用。
J Biol Chem. 2001 Oct 12;276(41):37839-45. doi: 10.1074/jbc.M010606200. Epub 2001 Aug 1.
8
Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.环氧化酶、末端前列腺素合酶与磷脂酶A2之间的偶联
J Biol Chem. 2001 Sep 14;276(37):34918-27. doi: 10.1074/jbc.M100429200. Epub 2001 Jun 19.
9
Why there are two cyclooxygenase isozymes.为什么会有两种环氧化酶同工酶。
J Clin Invest. 2001 Jun;107(12):1491-5. doi: 10.1172/JCI13271.
10
Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.新型环氧化酶-2抑制剂塞来昔布的肾脏安全性及耐受性
Am J Ther. 2000 May;7(3):159-75. doi: 10.1097/00045391-200007030-00004.
Zotero 插件